glp-1 for inflammation The role of glucagon-like peptide-1 receptor (GLP-1R) agonists in enhancing endothelial function: a potential avenue improving heart failure with preserved ejection fraction (HFpEF) | Cardiovascular Diabetology Frontiers | GLP-1 RAs and

Liraglutide not only blocks insulin receptor and synaptic loss in the brain but also reverses memory impairment induced by AD-associated A oligomers, suggesting that GLP-1R activation may be used to protect brain insulin receptors and synapses in AD ( 3.2 Neuroinflammation AD and DM are significantly associated with neuroinflammatory mechanisms

Most protocols require reorders every 46 weeks depending on dose frequency

For FY27, the report estimates an incremental revenue opportunity of 1,0002,000 crore in Indias branded formulations market, 4,500 crore in regulated markets such as Canada and Brazil, and 500-1,000 crore in emerging markets

Discovery of potent and selective inhibitors of phosphodiesterase 1 for the treatment of cognitive impairment associated with neurodegenerative and neuropsychiatric diseases